A Study of PAD Followed by Autologous Stem Cell Transplantation (ASCT) to Treat Newly Diagnosed Multiple Myeloma

Clinical trial NCT01852799 · COMPLETED

Trial details

NCT number: NCT01852799
Sponsor: Shanghai Changzheng Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2012-12-01
Primary completion: 2016-09-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.